1. US FDA warning about compounded ophthalmic injections

   News item 30 June 2018 Pages: 1 - 1

2. Alemtuzumab-induced thyroid dysfunction examined

   Clinical study 30 June 2018 Pages: 2 - 2

3. Antipsychotics in youths: metabolic effects

   Clinical study 30 June 2018 Pages: 3 - 3

4. Association between abiraterone and rhabdomyolysis

   Clinical study 30 June 2018 Pages: 4 - 4

5. Cardiovascular AEs with immune checkpoint inhibitors

   Clinical study 30 June 2018 Pages: 5 - 5

6. Drug-induced Parkinsonism with tamoxifen

   Clinical study 30 June 2018 Pages: 6 - 6

7. Fluconazole associated with stillbirth/neonatal death?

   Clinical study 30 June 2018 Pages: 7 - 7

8. Harmful association between antidepressants and EPS

   Epidemiology clinical study 30 June 2018 Pages: 8 - 8

9. Increased risk of psoriasiform diseases with anti-TNF agents

   Clinical study 30 June 2018 Pages: 9 - 9

10. Lithium use during pregnancy needs balanced decision making

    Review 30 June 2018 Pages: 10 - 10

11. Malignant melanoma with hydrochlorothiazide

    Clinical study 30 June 2018 Pages: 11 - 11

12. Risk of spontaneous abortion not increased by 4vHPV vaccine

    Clinical study 30 June 2018 Pages: 12 - 12

13. Safety of adalimumab in patients with Crohn's disease

    Clinical study 30 June 2018 Pages: 13 - 13

14. ACE inhibitors

    Case report 30 June 2018 Pages: 14 - 15

15. Acenocoumarol

    Case report 30 June 2018 Pages: 15 - 15

16. Acetylcysteine/paracetamol overdose

    Case report 30 June 2018 Pages: 16 - 16

17. Acitretin

    Case report 30 June 2018 Pages: 17 - 17

18. Acitretin/isotretinoin

    Case report 30 June 2018 Pages: 18 - 18

19. Adalimumab

    Case report 30 June 2018 Pages: 19 - 19

20. Adalimumab

    Case report 30 June 2018 Pages: 20 - 20

21. Adalimumab

    Case report 30 June 2018 Pages: 21 - 21

22. Adalimumab

    Case report 30 June 2018 Pages: 22 - 22

23. Adalimumab/etanercept

    Case report 30 June 2018 Pages: 23 - 23

24. Adalimumab/infliximab

    Case report 30 June 2018 Pages: 24 - 24

25. Adalimumab/infliximab

    Case report 30 June 2018 Pages: 25 - 25

26. Adefovir dipivoxil

    Case report 30 June 2018 Pages: 26 - 26

27. Afatinib

    Case report 30 June 2018 Pages: 27 - 27

28. Afatinib/gefitinib

    Case report 30 June 2018 Pages: 28 - 28

29. Aflibercept

    Case report 30 June 2018 Pages: 29 - 29

30. Alendronic-acid

    Case report 30 June 2018 Pages: 30 - 30

31. Allopurinol

    Case report 30 June 2018 Pages: 31 - 31

32. Alteplase

    Case report 30 June 2018 Pages: 32 - 32

33. Amantadine

    Case report 30 June 2018 Pages: 33 - 33

34. Amiodarone

    Case report 30 June 2018 Pages: 34 - 34

35. Amlodipine

    Case report 30 June 2018 Pages: 35 - 35

36. Amoxicillin

    Case report 30 June 2018 Pages: 36 - 36

37. Amoxicillin/moxifloxacin/rabeprazole

    Case report 30 June 2018 Pages: 37 - 37

38. Anaesthetics/ketorolac/paracetamol

    Case report 30 June 2018 Pages: 38 - 38

39. Anti-neoplastics

    Case report 30 June 2018 Pages: 39 - 39

40. Antibacterials

    Case report 30 June 2018 Pages: 40 - 40

41. Antibacterials/edaravone

    Case report 30 June 2018 Pages: 41 - 41

42. Antibacterials/immunosuppressants

    Case report 30 June 2018 Pages: 42 - 42

43. Antibiotics

    Case report 30 June 2018 Pages: 43 - 43

44. Antibiotics

    Case report 30 June 2018 Pages: 44 - 44

45. Antihyperglycaemics

    Case report 30 June 2018 Pages: 45 - 45

46. Antineoplastics

    Case report 30 June 2018 Pages: 46 - 46

47. Antineoplastics

    Case report 30 June 2018 Pages: 47 - 47

48. Antineoplastics

    Case report 30 June 2018 Pages: 48 - 48

49. Antineoplastics

    Case report 30 June 2018 Pages: 49 - 49

50. Antineoplastics and corticosteroids

    Case report 30 June 2018 Pages: 50 - 50